Faculty of Medicine, University of Porto, Porto, Portugal.
Faculty of Medicine, University of Porto, Porto, Portugal -
Int Angiol. 2024 Aug;43(4):411-420. doi: 10.23736/S0392-9590.24.05279-9. Epub 2024 Sep 18.
Stent-assisted, balloon-induced intimal disruption and relamination of aortic dissection (STABILISE) is an extended downstream endovascular management technique for acute type B aortic dissection (TBAD), that aimed to achieve complete aortic remodeling. This systematic review aimed to assess the early and mid-term clinical outcomes with STABILISE in the management of TBAD.
A literature search was performed on the Medline, Web of Science, Scopus, and SciELO databases, which returned 195 studies. Five studies were included. Data were extracted using predefined forms.
In total, one hundred patients with acute or subacute TBAD managed with STABILISE were included. All studies reported a technical success of 100%. Thirty-day mortality was estimated at 4% (4/100) with no further deaths documented during an estimated mean follow-up of 12.7 months (range 12-15 months). Five percent developed spinal cord ischemia and another 5% developed visceral artery occlusions. One case of aortic rupture during time of balloon inflation was reported. Rare complications included delayed retrograde dissection (1%), aortobronchial fistula (1%), and renal failure (1%). One case of disconnection between stent-graft and bare stent was documented. Six percent of patients developed endoleak, predominately type I. Overall re-intervention rate was 21%, as reported in all studies. Complete obliteration of the false lumen in the thoracic aorta was achieved in 99% of patients and in the abdominal aorta in 96% of patients.
STABILISE technique carries promising early and mid-term outcomes with high technical success and low mortality and morbidity. Excellent results on complete false lumen obliteration were observed. However, the heterogeneity among available studies' methodology does not permit firm conclusions, and further prospective analyses are needed to study the long-term outcomes of STABILISE.
支架辅助、球囊诱导的主动脉夹层内膜撕裂和再分层(STABILISE)是一种急性 B 型主动脉夹层(TBAD)的下游血管内扩展治疗技术,旨在实现完全的主动脉重塑。本系统评价旨在评估 STABILISE 在 TBAD 治疗中的早期和中期临床结果。
在 Medline、Web of Science、Scopus 和 SciELO 数据库上进行了文献检索,共检索到 195 项研究。纳入了 5 项研究。使用预设表格提取数据。
共有 100 例急性或亚急性 TBAD 患者接受 STABILISE 治疗,所有研究均报告技术成功率为 100%。30 天死亡率估计为 4%(4/100),在估计的平均随访 12.7 个月(范围 12-15 个月)期间没有进一步死亡记录。5%的患者发生脊髓缺血,另有 5%的患者发生内脏动脉闭塞。在球囊充气过程中报告了 1 例主动脉破裂的病例。罕见并发症包括迟发性逆行夹层(1%)、主动脉支气管瘘(1%)和肾功能衰竭(1%)。有 1 例记录到支架移植物和裸支架之间的连接断开。6%的患者发生了内漏,主要是 I 型。所有研究均报告总体再干预率为 21%。99%的患者胸主动脉假腔完全闭塞,96%的患者腹主动脉假腔完全闭塞。
STABILISE 技术具有较高的技术成功率、较低的死亡率和发病率,具有良好的早期和中期结果。观察到完全闭塞假腔的效果非常好。然而,由于现有研究方法学的异质性,无法得出明确的结论,需要进一步的前瞻性分析来研究 STABILISE 的长期结果。